Recent Posts
RespiratoryRESPIRATORY
4 Sites on 1600 SubjectsRespiratory Novel BiologicPHASE IV
Synagis observational Epidemiologic Trial about Lower Respiratory Infections in pediatrics population. ABBOTT 2008
RespiratoryPHASE III
Protocol Nr. 04431. A 12-week efficiency and safety study of two doses of mometasone furoate/formoterol combination formulation compared with mometasone fuorate monotherapy, in persistent asmathics previously treated with high dose inhaled glucocorticosteriods. SCHERING PLOUGH 2008
4 Sites on 20 SubjectsRespiratoryPHASE III
SPRI P04705. A 52-week efficacy and safety study non-inferiority study of fluticasone/sameterol 250/50 BID Diskus vs Mometasona/formoterol 200/10 mcg BID MDI in persistent asmathics previously treated wit medium doses of inhaled glucorticosteroids. SCHERING PLOUGH 2007
2 Sites and 20 SubjectsRespiratory Phase III
Protocol Nr. 04230. A randomized placebo-controlled efficacy and safety study of one year treatment duration with high and medium-dose ihaled mometasone furoate monotherapy with moderate to severe COPD. SCHERING PLOUGH 2007
10 Sites on 300 SubjectsCardiovascularPHASE III
Valsartan. Phase III Triasl to assess the efficacy and safety of valsartan alone and in combination with hydroclorothiazide with or amlodipine for aterial hypertension control. NOVARTIS 2005-2008
3 Sites and 30 subjectsRespiratoryPHASE III
Protocol Nr. P04073. A 26-week placebo-controlled efficacy and safety study of mometasone furoate/formoterol furoate combination formulation compared with mometasone furoate and formoterol monotherapy in subjects with persistent asthma previously treated with low-dose ihaled glucocorticosteroids. SCHERING PLOUGH 2007
4 Sites and 40 subjectsRespiratoryPhase III
INDICATEROL. Phase III trial to assess the efficacy and safety of Indacaterol two daily doses compared to placebo and tiotropium. Five comparative groups. PK/PD vs respiratory functional ttest were performed. NOVARTIS 2006-2008
8 Sites and 80 subjectsRespiratoryPhase IV
PEACE: Phase IV randomized, multicenter double-blind, double dummy comparative trial with the combination salmeterol/fluticasone propionate (50/100mcg BID) inhaled via DISKUS and montelukast oral (5 MG QD ) (chewable tablets) in children aged from 6 to 14 and/or with persistent asthma. GSK 2006-2007
2 Sites and 40 subjectsRespiratoryPhase IV
Short Term anti-tuberculosis therapy in tuberculosis meningitis. CIBA-GEIGY 1988-1990
Accuracy Research has a multidisciplinary team of highly qualified and trained personnel committed to carrying out fully compliant clinical research.
Menu
© 2024 ACCURACY RESEARCH. HEALTH CONSULTING & CONTRACT RESEARCH ORGANIZATION. Investigación en Salud. Cía. Ltda